Acadia Pharmaceuticals | ACAD - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05
FY2025Q2 Jun/2025 0.16 0.15 0.20 Aug/06
FY2025Q1 Mar/2025 0.11 0.01 0.10 May/07




Eps Alterar Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
ALKERMES USD -0.4 0.69 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Cara Therapeutics USD -0.59 4.45 2025-09
Corcept Therapeutics USD -0.3 0.5 2026-03
Cytokinetics USD -1.67 0.17 2026-03
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Incyte USD 1.81 0.01 2026-03
J&J USD 2.7 0.24 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
Pfizer USD 0.75 0.09 2026-03
Prothena USD 0.6 1.06 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vanda Pharmaceuticals USD -0.09 0 2024-12
Vertex Pharmaceuticals USD 4.47 0.56 2026-03